日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world clinical utility of comprehensive genomic profiling in advanced solid tumors

全面基因组分析在晚期实体瘤中的实际临床应用价值

Saito, Yuki; Horie, Sara; Kogure, Yasunori; Mizuno, Kota; Ito, Yuta; Mizukami, Yosuke; Kim, Haryoon; Tamura, Zen; Koya, Junji; Funakoshi, Takeru; Hirata, Kenro; Kataoka, Keisuke

Lymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study

自身免疫性疾病合并多种药物治疗的淋巴瘤风险:LIFE 研究分析

Inokuchi, Ami; Kim, Haryoon; Sakurai, Masatoshi; Masuda, Kyoko; Mizuno, Kota; Koda, Yuya; Matsuki, Eri; Kogure, Yasunori; Ukita, Shoko; Maeda, Megumi; Oda, Futoshi; Kaneko, Yuko; Sato, Yasunori; Fukuda, Haruhisa; Kataoka, Keisuke

Obinutuzumab maintenance versus observation for patients with newly diagnosed high tumor burden follicular lymphoma who achieved complete metabolic response after obinutuzumab plus bendamustine induction therapy: a multicenter, randomized, phase III study (JCOG2008, MAIN study)

对于新诊断的高肿瘤负荷滤泡性淋巴瘤患者,在接受奥妥珠单抗联合苯达莫司汀诱导治疗后达到完全代谢缓解,奥妥珠单抗维持治疗与观察治疗的比较:一项多中心、随机、III期研究(JCOG2008,MAIN研究)

Kobayashi, Tsutomu; Ishizawa, Kenichi; Machida, Ryunosuke; Sadachi, Ryo; Sasaki, Keita; Kim, Haryoon; Kataoka, Keisuke; Munakata, Wataru; Fukuhara, Noriko; Nagai, Hirokazu

Modeling NK-cell lymphoma in mice reveals its cell-of-origin and microenvironmental changes and identifies therapeutic targets

在小鼠中构建NK细胞淋巴瘤模型,可以揭示其细胞起源和微环境变化,并确定治疗靶点。

Koya, Junji; Tanigawa, Tomohiko; Mizuno, Kota; Kim, Haryoon; Ito, Yuta; Yuasa, Mitsuhiro; Yamaguchi, Kentaro; Kogure, Yasunori; Saito, Yuki; Shingaki, Sumito; Tabata, Mariko; Murakami, Koichi; Chiba, Kenichi; Okada, Ai; Shiraishi, Yuichi; Marouf, Amira; Liévin, Raphaël; Chaubard, Sammara; Jaccard, Arnaud; Hermine, Olivier; de Leval, Laurence; Tournilhac, Olivier; Damaj, Gandhi; Gaulard, Philippe; Couronné, Lucile; Yasui, Teruhito; Nakashima, Kazutaka; Miyoshi, Hiroaki; Ohshima, Koichi; Kataoka, Keisuke